A recent study showed that the topotecan-resistant- and doxorubicin-resistant human ovary carcinoma cell line show ABCB1 expression in both nuclear and plasma membranes, but tunicamycin-treated cells show ABCB1 mainly in the cytoplasm. The gene discussed is ABCB1; the disease is ovarian carcinoma.